Gene Symbol | Pearson Correlation Coefficient |
---|---|
PSMA1 | 0.964 |
PSMD6 | 0.96 |
XRCC6 | 0.953 |
PSMD14 | 0.952 |
SNRPB2 | 0.952 |
ILF2 | 0.951 |
PSMA3 | 0.951 |
PPA1 | 0.951 |
MYL12B | 0.95 |
PSMC2 | 0.948 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.753 |
OR4F29 | -0.727 |
MTRNR2L6 | -0.252 |
MTRNR2L9 | -0.252 |
P2RY14 | -0.23 |
MTRNR2L10 | -0.228 |
C8orf74 | -0.197 |
TRPV5 | -0.189 |
MTRNR2L1 | -0.188 |
MTRNR2L3 | -0.183 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB08515 | (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE | Small Molecule | Experimental | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in increased expression of PSMA6 mRNA" | 15375163 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMA6 mRNA" | 25639565 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMA6 mRNA]" | 25639565 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PSMA6 mRNA" | 19114083 |
C066841 | 2,3,7,8-tetrabromodibenzo-4-dioxin | "2,3,7,8-tetrabromodibenzo-4-dioxin results in increased expression of PSMA6 protein" | 27604104 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of PSMA6 mRNA" | 21346803 |
C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of PSMA6 mRNA" | 15215175 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of PSMA6 mRNA | 25704631 |
D000638 | Amiodarone | Amiodarone affects the expression of PSMA6 mRNA | 19483382 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PSMA6 mRNA | 16483693 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of PSMA6 mRNA | 20458559 |
D001553 | Benzbromarone | Benzbromarone affects the expression of PSMA6 mRNA | 19483382 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PSMA6 protein | 20097212 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PSMA6 mRNA | 21839799 |
D004958 | Estradiol | [bisphenol A co-treated with Estradiol] results in decreased expression of PSMA6 mRNA | 26496021 |
C006780 | bisphenol A | bisphenol A results in decreased expression of PSMA6 mRNA | 29275510 |
C006780 | bisphenol A | [bisphenol A co-treated with Estradiol] results in decreased expression of PSMA6 mRNA | 26496021 |
C006780 | bisphenol A | bisphenol A results in decreased expression of PSMA6 mRNA | 26982218 |
C006780 | bisphenol A | bisphenol A results in increased expression of PSMA6 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of PSMA6 gene | 28505145 |
C423844 | BL 11282 | BL 11282 results in decreased expression of PSMA6 protein | 17458497 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of PSMA6 mRNA | 15336504 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of PSMA6 mRNA | 23741332 |
C100187 | chloropicrin | chloropicrin results in increased expression of PSMA6 mRNA | 26352163 |
D002994 | Clofibrate | Clofibrate affects the expression of PSMA6 mRNA | 19483382 |
D002994 | Clofibrate | Clofibrate results in increased expression of PSMA6 mRNA | 21318169 |
D003300 | Copper | Copper results in increased expression of PSMA6 mRNA | 18522721 |
C029892 | cupric chloride | cupric chloride results in increased expression of PSMA6 mRNA | 24650576 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of PSMA6 mRNA | 20106945 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of PSMA6 protein | 16400681 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of PSMA6 mRNA | 21318169 |
D004317 | Doxorubicin | Doxorubicin results in increased metabolism of PSMA6 protein | 17346995 |
D004785 | Environmental Pollutants | Environmental Pollutants affects the expression of PSMA6 mRNA | 19118595 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of PSMA6 mRNA | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of PSMA6 mRNA | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMA6 mRNA | 17942748 |
D005001 | Ethionine | Ethionine affects the expression of PSMA6 mRNA | 19483382 |
D005485 | Flutamide | Flutamide results in increased expression of PSMA6 mRNA | 24136188 |
C492448 | ICG 001 | ICG 001 results in increased expression of PSMA6 mRNA | 26191083 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PSMA6 mRNA | 25613284 |
C410337 | K 7174 | K 7174 results in decreased expression of PSMA6 mRNA | 24086573 |
D048628 | Ketolides | Ketolides analog results in decreased expression of PSMA6 mRNA | 24967691 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PSMA6 mRNA" | 19264136 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PSMA6 mRNA | 25613284 |
D008148 | Lovastatin | Lovastatin results in decreased expression of PSMA6 mRNA | 20493250 |
D009151 | Mustard Gas | Mustard Gas affects the expression of PSMA6 mRNA | 15651846 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of PSMA6 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of PSMA6 mRNA" | 25554681 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of PSMA6 mRNA | 12832660 |
C051752 | nefazodone | nefazodone results in increased expression of PSMA6 mRNA | 24136188 |
C012655 | nimesulide | nimesulide results in increased expression of PSMA6 mRNA | 24136188 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of PSMA6 mRNA | 17616710 |
D009853 | Omeprazole | Omeprazole affects the expression of PSMA6 mRNA | 19483382 |
C016340 | o,p'-DDT | "o,p'-DDT affects the expression of PSMA6 mRNA" | 17984292 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of PSMA6 mRNA | 19429403 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of PSMA6 mRNA | 20936131 |
C076994 | perfluorooctane sulfonic acid | PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMA6 mRNA] | 20936131 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of PSMA6 mRNA | 19429403 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of PSMA6 mRNA | 19162173|2131816 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of PSMA6 mRNA | 18301758|2381119 |
C006253 | pirinixic acid | pirinixic acid affects the expression of PSMA6 mRNA | 19483382 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of PSMA6 mRNA | 23557933 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of PSMA6 mRNA | 19162173|2131816 |
C045950 | propiconazole | propiconazole results in increased expression of PSMA6 mRNA | 21278054 |
C015586 | propiverine | propiverine binds to PSMA6 protein | 29273565 |
D011441 | Propylthiouracil | Propylthiouracil affects the expression of PSMA6 mRNA | 19483382 |
C012526 | quercitrin | quercitrin results in decreased expression of PSMA6 mRNA | 25193878 |
C080703 | SK&F 83959 | SK&F 83959 results in decreased expression of PSMA6 protein | 25852303 |
D013605 | T-2 Toxin | T-2 Toxin affects the expression of PSMA6 protein | 26141394 |
D013629 | Tamoxifen | Tamoxifen affects the expression of PSMA6 mRNA | 17555576 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PSMA6 mRNA | 21570461|2468072 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMA6 mRNA | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PSMA6 protein | 19201780 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PSMA6 mRNA | 25613284 |
D013853 | Thioacetamide | Thioacetamide affects the expression of PSMA6 mRNA | 19483382 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of PSMA6 protein | 22595367 |
D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of PSMA6 mRNA | 21346803 |
C005865 | troxerutin | "troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMA6 mRNA]" | 25639565 |
C406224 | valdecoxib | valdecoxib results in increased expression of PSMA6 mRNA | 24136188 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PSMA6 mRNA | 21318169 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of PSMA6 gene | 25560391 |
D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of PSMA6 mRNA | 20044591 |
D014859 | Warfarin | Warfarin results in decreased expression of PSMA6 mRNA | 20493250 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003723 | RNA binding | - | IDA | 7681138 |
GO:0003723 | RNA binding | - | NAS | 7681138 |
GO:0004175 | endopeptidase activity | - | IBA | 21873635 |
GO:0004175 | endopeptidase activity | - | NAS | 7681138 |
GO:0004298 | threonine-type endopeptidase activity | - | IEA | - |
GO:0005515 | protein binding | - | IPI | 14733938 15225636 15887188 16169070 16990800 17948026 18922472 19490896 19581590 25416956 |
GO:0035639 | purine ribonucleoside triphosphate binding | - | NAS | 7681138 |
GO:0051059 | NF-kappaB binding | - | IPI | 14743216 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006511 | ubiquitin-dependent protein catabolic process | - | IEA | - |
GO:0010498 | proteasomal protein catabolic process | - | IBA | 21873635 |
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | - | IBA | 21873635 |
GO:0016579 | protein deubiquitination | - | TAS | - |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | - | IBA | 21873635 |
GO:0043687 | post-translational protein modification | - | TAS | - |
GO:0050727 | regulation of inflammatory response | - | IC | 16845397 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | - | IMP | 16845397 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | - | IMP | 16845397 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000502 | proteasome complex | - | IDA | 17323924 |
GO:0000932 | P-body | - | ISS | - |
GO:0005634 | nucleus | - | HDA | 21630459 |
GO:0005634 | nucleus | - | IBA | 21873635 |
GO:0005634 | nucleus | - | IDA | 7681138 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005737 | cytoplasm | - | IBA | 21873635 |
GO:0005829 | cytosol | - | TAS | - |
GO:0005839 | proteasome core complex | - | IBA | 21873635 |
GO:0005839 | proteasome core complex | - | ISS | - |
GO:0005839 | proteasome core complex | - | NAS | 1888762 |
GO:0005844 | polysome | - | IDA | 7681138 |
GO:0016363 | nuclear matrix | - | ISS | - |
GO:0019773 | proteasome core complex, alpha-subunit complex | - | IBA | 21873635 |
GO:0019773 | proteasome core complex, alpha-subunit complex | - | IDA | 9096325 |
GO:0019773 | proteasome core complex, alpha-subunit complex | - | ISS | - |
GO:0019773 | proteasome core complex, alpha-subunit complex | - | TAS | 11917093 |
GO:0030016 | myofibril | - | ISS | - |
GO:0030017 | sarcomere | - | ISS | - |
GO:0070062 | extracellular exosome | - | HDA | 20458337 |
KEGG ID | KEGG Term |
---|---|
hsa03050 | Proteasome |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109581 | Apoptosis | IEA |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | TAS |
R-HSA-1169091 | Activation of NF-kappaB in B cells | TAS |
R-HSA-1234174 | Regulation of Hypoxia-inducible Factor (HIF) by oxygen | TAS |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | TAS |
R-HSA-1236974 | ER-Phagosome pathway | IEA |
R-HSA-1236975 | Antigen processing-Cross presentation | TAS |
R-HSA-1236975 | Antigen processing-Cross presentation | IEA |
R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | TAS |
R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
R-HSA-1266738 | Developmental Biology | IEA |
R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
R-HSA-1280218 | Adaptive Immune System | TAS |
R-HSA-1280218 | Adaptive Immune System | IEA |
R-HSA-1430728 | Metabolism | TAS |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-162906 | HIV Infection | TAS |
R-HSA-162909 | Host Interactions of HIV factors | TAS |
R-HSA-1640170 | Cell Cycle | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-168256 | Immune System | IEA |
R-HSA-169911 | Regulation of Apoptosis | IEA |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | TAS |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | TAS |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | TAS |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | TAS |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | TAS |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | TAS |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | TAS |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | TAS |
R-HSA-180534 | Vpu mediated degradation of CD4 | TAS |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | TAS |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | TAS |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | TAS |
R-HSA-195721 | Signaling by WNT | TAS |
R-HSA-201681 | TCF dependent signaling in response to WNT | TAS |
R-HSA-202403 | TCR signaling | TAS |
R-HSA-202424 | Downstream TCR signaling | TAS |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | IEA |
R-HSA-212436 | Generic Transcription Pathway | IEA |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-2262749 | Cellular response to hypoxia | TAS |
R-HSA-2262752 | Cellular responses to stress | TAS |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | TAS |
R-HSA-2467813 | Separation of Sister Chromatids | TAS |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | TAS |
R-HSA-2871837 | FCERI mediated NF-kB activation | TAS |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | TAS |
R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | TAS |
R-HSA-351202 | Metabolism of polyamines | TAS |
R-HSA-376176 | Signaling by ROBO receptors | IEA |
R-HSA-382551 | Transport of small molecules | TAS |
R-HSA-382556 | ABC-family proteins mediated transport | TAS |
R-HSA-3858494 | Beta-catenin independent WNT signaling | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-4086400 | PCP/CE pathway | TAS |
R-HSA-422475 | Axon guidance | IEA |
R-HSA-446652 | Interleukin-1 family signaling | TAS |
R-HSA-449147 | Signaling by Interleukins | TAS |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | TAS |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | TAS |
R-HSA-453274 | Mitotic G2-G2/M phases | TAS |
R-HSA-453276 | Regulation of mitotic cell cycle | TAS |
R-HSA-453279 | Mitotic G1-G1/S phases | TAS |
R-HSA-4608870 | Asymmetric localization of PCP proteins | TAS |
R-HSA-4641257 | Degradation of AXIN | TAS |
R-HSA-4641258 | Degradation of DVL | TAS |
R-HSA-5357801 | Programmed Cell Death | IEA |
R-HSA-5358346 | Hedgehog ligand biogenesis | TAS |
R-HSA-5358351 | Signaling by Hedgehog | TAS |
R-HSA-5358351 | Signaling by Hedgehog | IEA |
R-HSA-5362768 | Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | TAS |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | TAS |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | TAS |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | TAS |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | TAS |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | IEA |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | TAS |
R-HSA-5610787 | Hedgehog 'off' state | IEA |
R-HSA-5610787 | Hedgehog 'off' state | TAS |
R-HSA-5619084 | ABC transporter disorders | TAS |
R-HSA-5619115 | Disorders of transmembrane transporters | TAS |
R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
R-HSA-5632684 | Hedgehog 'on' state | TAS |
R-HSA-5658442 | Regulation of RAS by GAPs | TAS |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-5663205 | Infectious disease | TAS |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | TAS |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | TAS |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-5687128 | MAPK6/MAPK4 signaling | TAS |
R-HSA-5688426 | Deubiquitination | TAS |
R-HSA-5689603 | UCH proteinases | TAS |
R-HSA-5689880 | Ub-specific processing proteases | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-6807070 | PTEN Regulation | TAS |
R-HSA-68827 | CDT1 association with the CDC6:ORC:origin complex | TAS |
R-HSA-68867 | Assembly of the pre-replicative complex | TAS |
R-HSA-68874 | M/G1 Transition | TAS |
R-HSA-68882 | Mitotic Anaphase | TAS |
R-HSA-68886 | M Phase | TAS |
R-HSA-68949 | Orc1 removal from chromatin | TAS |
R-HSA-69002 | DNA Replication Pre-Initiation | TAS |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | TAS |
R-HSA-69052 | Switching of origins to a post-replicative state | TAS |
R-HSA-69202 | Cyclin E associated events during G1/S transition | TAS |
R-HSA-69206 | G1/S Transition | TAS |
R-HSA-69229 | Ubiquitin-dependent degradation of Cyclin D1 | TAS |
R-HSA-69239 | Synthesis of DNA | TAS |
R-HSA-69242 | S Phase | TAS |
R-HSA-69275 | G2/M Transition | TAS |
R-HSA-69278 | Cell Cycle, Mitotic | TAS |
R-HSA-69306 | DNA Replication | TAS |
R-HSA-69481 | G2/M Checkpoints | TAS |
R-HSA-69541 | Stabilization of p53 | TAS |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | TAS |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | TAS |
R-HSA-69601 | Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | TAS |
R-HSA-69610 | p53-Independent DNA Damage Response | TAS |
R-HSA-69613 | p53-Independent G1/S DNA damage checkpoint | TAS |
R-HSA-69615 | G1/S DNA Damage Checkpoints | TAS |
R-HSA-69620 | Cell Cycle Checkpoints | TAS |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | TAS |
R-HSA-71291 | Metabolism of amino acids and derivatives | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | IEA |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | IEA |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | TAS |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | TAS |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | TAS |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | TAS |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | IEA |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | TAS |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | TAS |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | IEA |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | TAS |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | TAS |
R-HSA-8948751 | Regulation of PTEN stability and activity | TAS |
R-HSA-8951664 | Neddylation | TAS |
R-HSA-8953854 | Metabolism of RNA | TAS |
R-HSA-8953897 | Cellular responses to external stimuli | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | IEA |
R-HSA-9020702 | Interleukin-1 signaling | TAS |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | TAS |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | TAS |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | IEA |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
18157711 | Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. (2009 Jan) | Banerjee I | J Thromb Thrombolysis |